Iran with 12 research teams has joined WHO clinical trials on four anti-coronavirus drugs, Malekzadeh wrote on his Instagram page on Tuesday.
Clinical trials are a type of research that studies new tests and treatments and evaluates their effects on human health outcomes.
Malekzadeh said that WHO has reported clinical trials on four drugs used to treat HIV as well as Chloroquine and hydroxychloroquine, Remdesivir (used to treat Ebola), and Lopinavir/Ritonavir.
Iran which enjoys one of the biggest medical research capacities in the region and among the Islamic countries has joined WHO clinical trials with 12 research teams.
Medical Officer at Department of Immunization Vaccines and Biologicals of the World Health Organization Ana Maria Henao Restrepo expressed hope that thousands of patients around the world would join this study.
Iran, South Africa, Argentina, France, Spain, Germany, Netherlands, Belgium, Luxembourg, and the UK have so far joined the trials.
The coronavirus COVID-19 is affecting over 180 countries and territories around the world. The virus was first reported in the central Chinese city of Wuhan late last year. It has so far killed more than 19,000 people and infected over 423,000 others globally.
Iran reported on Tuesday that a total number of 1,934 coronavirus patients have died and 24,811 cases of infection have been identified in the country so far. Meanwhile, 8,931 people have also recovered.
The Iranian foreign ministry declared that despite Washington’s claims of cooperation to transfer drugs to Iran via the new Swiss-launched payment mechanism, the US is troubling the process amid the coronavirus outbreak in the country.
Although US claims that medicines and medical equipment are not under sanctions, they have practically blocked the transfer of Iran’s financial resources in other countries into the Swiss Humanitarian Trade Arrangement (SHTA), Iranian Foreign Ministry Spokesman Seyed Abbas Mousavi said.
As the death toll from the virus surges, Iran intensifies its preventive safety measures. Closures of schools and universities have been extended until early April.
The government also imposed travel restrictions, specially on Iran’s north, which is among the red zones. The country has also adopted strict digital health control procedures at airports to spot possible infections.
Health Minister Saeed Namaki announced earlier this month that a new national mobilization plan would be implemented across the country to fight against the coronavirus epidemic and more effectively treat patients.
Namaki said that the plan will include all the 17,000 health centers and the 9,000 medical and clinical centers in all cities, suburban areas and villages.
He added that the plan will include home quarantine, noting that infected people will receive the necessary medicines and advice, but they are asked to stay at home.
Namaki said that people with a more serious condition will stay at the hospitals, adding that the public places will be disinfected, the entries of infected towns and cities will be controlled to diagnose and quarantine the infected cases.
He added that the necessary equipment and facilities have been provided, expressing the hope that the epidemic would be curbed.
Namaki said that the number of medical laboratories to test coronavirus infection has reached 22, and will increase to 40 soon.
The World Health Organization (WHO) says Iran's response to the virus has so far been up to the mark. Still, it says the US sanctions are a big challenge, and Washington would be complicit in the rising death toll in Iran if it would not remove its sanctions.
The World Health Organization has considered priorities in combating coronavirus and Islamic Republic of Iran obeys and follows up priorities as defined by WHO.
The WHO is dispatching separate delegations to all countries.